Low Neurophysiologic Resistance to Anesthetics as a Marker of Preclinical/Prodromal Alzheimer's Disease and Neurovascular Pathology, Delirium risk and Inattention
Low Neurophysiologic Resistance to Anesthetics as a Marker of Preclinical/Prodromal Alzheimer's Disease and Neurovascular Pathology, Delirium risk and Inattention
批准号:
10521860
负责人:
Miles Berger
金额:
$78.42万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-08-01 至 2027-04-30
关键词:
AgeAlzheimer&aposs DiseaseAlzheimer&aposs disease pathologyAlzheimer&aposs disease related dementiaAlzheimer&aposs disease riskAmericanAmyloid beta-ProteinAnesthesia proceduresAnestheticsAttentionBiological MarkersBrainBrain PathologyBrain imagingBrain regionCaringCerebrospinal FluidClinicalCognitiveCohort StudiesDataDeliriumDementiaDepositionDevelopmentDiseaseDoseElderlyElectroencephalographyExerciseFoundationsFunctional Magnetic Resonance ImagingFunctional disorderFutureGoalsImageImpaired cognitionIncidenceInterventionLinkMagnetic Resonance ImagingMeasuresMedialMemoryMemory impairmentMonitorMyocardial dysfunctionNeurocognitiveOperating RoomsOperative Surgical ProceduresOutcomeParietalPathologyPatientsPatternPerioperativePharmacologyPhaseProteinsPsyche structureResistanceRestRiskSeveritiesSignal TransductionSpinal PunctureStress TestsStructureSurgeonSymptomsSyndromeTemporal LobeThalamic structureThallium Myocardial Perfusion Imaging Stress TestThinkingThoracic Surgical ProceduresTimeVascular DementiaWaxesWorkaging brainalertnessbeta amyloid pathologybrain abnormalitiesbrain dysfunctioncognitive testingdosagefollow-upfunctional MRI scanhuman old age (65+)inattentionindexingneurocognitive disorderneuroimagingneuropathologyneurophysiologyneurovascularneurovascular injuryolder patientpostoperative deliriumpre-clinicalpreventprodromal Alzheimer&aposs diseaseprospectiveresponsescreeningskillsstandard of carestressortau Proteinstau-1white matter
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Delirium is a syndrome of fluctuating changes in alertness and attention that occurs in up to 40% of older
surgical patients (i.e. age >65. Delirium is associated with an increased risk of developing dementia, a
progressive loss of thinking and memory skills that eventually results in an inability to care for oneself and to
live independently. The most common cause of dementia in older Americans is Alzheimer’s disease (AD)
which is associated with a progressive buildup of abnormal deposits in the brain of two proteins, tau and
amyloid beta. Amyloid beta deposits typically develop in the brain for years if not decades before the start of
memory deficits and other AD symptoms. Patients with these early or “pre-clinical” amyloid beta deposits, even
if they appear mentally normal, are often at increased risk of developing delirium after surgery. Here, we will
examine whether these amyloid beta deposits, or other “pre-clinical” changes in brain structure and activity,
predispose patients to show larger than normal brain activity changes in response to anesthetic drugs given
during surgery. The central idea of this proposal is that an altered (or exaggerated) brain activity responses to
anesthetic drugs is a marker of an unhealthy brain, i.e. a brain with signs of “pre-clinical” AD and which is at
increased risk of postoperative delirium. First we will examine whether patients with evidence of brain amyloid
beta pathology (as measured by spinal fluid amyloid beta levels) have altered brain activity responses to
anesthetic drugs. Second, we will use brain imaging to determine whether changes early AD-like changes in
brain structure and connections are associated with altered brain activity responses to anesthetic drugs. Third,
we will determine whether altered brain activity responses to anesthetic drugs are associated with increased
postoperative delirium occurrence and severity. This work will help us understand mechanisms underlying
postoperative delirium and AD and related dementias, and the links between them. Further, this work will
provide a way for anesthesiologists (and surgeons) to use brain activity recording data already in wide use in
American operating rooms to predict which patients are likely to develop postoperative delirium and/or AD,
which could allow these patients to be selected for interventions to prevent these disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
APOE4 dependent regulation of CSF Complement Pathway Activation in the development of Alzheimer's Disease
-
批准号:10650372
-
项目类别:
-
资助金额:$78.47万
-
财政年份:2022
-
负责人:Miles Berger
-
依托单位:
Low Neurophysiologic Resistance to Anesthetics as a Marker of Preclinical/Prodromal Alzheimer's Disease and Neurovascular Pathology, Delirium risk and Inattention
-
批准号:10870632
-
项目类别:
-
资助金额:$33.63万
-
财政年份:2022
-
负责人:Miles Berger
-
依托单位:
Low Neurophysiologic Resistance to Anesthetics as a Marker of Preclinical/Prodromal Alzheimer's Disease and Neurovascular Pathology, Delirium risk and Inattention
-
批准号:10671023
-
项目类别:
-
资助金额:$74.98万
-
财政年份:2022
-
负责人:Miles Berger
-
依托单位:
APOE4 dependent regulation of CSF Complement Pathway Activation in the development of Alzheimer's Disease
-
批准号:10871775
-
项目类别:
-
资助金额:$40.22万
-
财政年份:2022
-
负责人:Miles Berger
-
依托单位:
Neuro-inflammation in Postoperative Cognitive Dysfunction: CSF and fMRI Studies
-
批准号:9390592
-
项目类别:
-
资助金额:$24.3万
-
财政年份:2017
-
负责人:Miles Berger
-
依托单位:
Neuro-inflammation in Postoperative Cognitive Dysfunction: CSF and fMRI Studies
-
批准号:10598925
-
项目类别:
-
资助金额:$21.48万
-
财政年份:2017
-
负责人:Miles Berger
-
依托单位:
Neuro-inflammation in Postoperative Cognitive Dysfunction: CSF and fMRI Studies
-
批准号:9898206
-
项目类别:
-
资助金额:$23.68万
-
财政年份:2017
-
负责人:Miles Berger
-
依托单位:
Neuro-inflammation in Postoperative Cognitive Dysfunction: CSF and fMRI Studies
-
批准号:10160751
-
项目类别:
-
资助金额:$23.58万
-
财政年份:2017
-
负责人:Miles Berger
-
依托单位:
The Significance of Perioperative Changes in CSF tau levels in the Elderly
-
批准号:9123506
-
项目类别:
-
资助金额:$10.93万
-
财政年份:2015
-
负责人:Miles Berger
-
依托单位:
Role of 5-HT1A-AR overexpression in affective disorders
-
批准号:7281976
-
项目类别:
-
资助金额:$3.01万
-
财政年份:2005
-
负责人:Miles Berger
-
依托单位:
Role of 5-HT1A-AR overexpression in affective disorders
-
批准号:6994244
-
项目类别:
-
资助金额:$3.01万
-
财政年份:2005
-
负责人:Miles Berger
-
依托单位:
Role of 5-HT1A-AR overexpression in affective disorders
-
批准号:7119041
-
项目类别:
-
资助金额:$3.01万
-
财政年份:2005
-
负责人:Miles Berger
-
依托单位: